NasdaqGS:INSMBiotechs
Is Insmed (INSM) Still Attractive After Recent Pullback And Strong Three Year Surge
If you are wondering whether Insmed at US$139.14 is priced for opportunity or already reflecting a lot of expectations, the starting point is to get very clear on what the current valuation actually says.
The share price pullback over the past week and month, with 7 day and 30 day returns of 3.3% and 15.6% declines, comes after a much stronger backdrop, including a 77.2% return over 1 year and a gain of more than 7x over 3 years.
Recent headlines around Insmed have focused on the broader...